Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

Overview of attention for article published in Blood Cancer Journal, February 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#36 of 1,314)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 10 news outlets

twitter: 30 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 14 news stories from 10 outlets.

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Morning Star, 14 Mar 2024

Announced strategic collaboration and equity investment from BioNTech for aggregate proceeds of $250 million upfront, plus…

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Stockwatch, 14 Mar 2024

Announced strategic collaboration and equity investment from BioNTech for aggregate proceeds of $250 million upfront, plus…

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Crwe World, 14 Mar 2024

Announced strategic collaboration and equity investment from BioNTech for aggregate proceeds of $250 million upfront, plus…

News story from Finanz Nachrichten on Thursday 14 March 2024

Finanz Nachrichten, 14 Mar 2024

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 10 additional news stories.